The effectiveness of chia seed in improving glycemic status: A systematic review and meta-analysis.

And insulin Chia seed Fasting blood glucose (FBG) Glycated hemoglobin (HbA1c) Glycemic status

Journal

Diabetes & metabolic syndrome
ISSN: 1878-0334
Titre abrégé: Diabetes Metab Syndr
Pays: Netherlands
ID NLM: 101462250

Informations de publication

Date de publication:
21 Jun 2024
Historique:
received: 12 01 2024
revised: 11 06 2024
accepted: 19 06 2024
medline: 26 6 2024
pubmed: 26 6 2024
entrez: 25 6 2024
Statut: aheadofprint

Résumé

This systematic review and meta-analysis aims to evaluate the effectiveness of chia seeds in improving glycemic status, including fasting blood glucose (FBG), glycated hemoglobin (HbA1c), and insulin. A comprehensive literature search was conducted on PubMed, Scopus, Web of Science, Cochrane, and Google Scholar up to January 2024. Randomized controlled trials (RCTs) assessing the effect of chia seeds on FBG, HbA1c, and/or insulin that meet our eligibility criteria were included. Version 2 of the Cochrane risk-of-bias tool (RoB2) was used to assess the quality of the included studies. Data were extracted and analyzed using a random-effects model and reported as weighted mean differences (WMD) with 95 % confidence intervals (CI). Subgroup and sensitivity analyses were also performed. The registration number was CRD42023441766. Out of 341 articles retrieved from the initial search, 8 RCTs (with 10 arms) involving 362 participants were included in the meta-analysis. The results showed that chia consumption had no significant effect on FBG (WMD: 0.79 %; 95 % CI: -0.97 to 2.55; p = 0.38), HbA1c (WMD: -0.12 %; 95 % CI: -0.27 to 0.02; p = 0.09), and insulin (WMD:1.23 %; 95 % CI: -1.77 to 4.22; p = 0.42). Chia seed consumption shows no significant impact on FBG, HbA1c, and insulin levels. This study is limited by the small number of studies in the meta-analysis and the significant heterogeneity among them, necessitating further research with larger sample sizes.

Identifiants

pubmed: 38917708
pii: S1871-4021(24)00126-7
doi: 10.1016/j.dsx.2024.103065
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103065

Informations de copyright

Copyright © 2024 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that there are no conflicts of interest regarding the publication of this paper. All authors have disclosed any potential conflicts of interest for the previous two years, and no conflicts were identified.

Auteurs

Pedram Pam (P)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Iman El Sayed (I)

Department of Biomedical Informatics and Medical Statistics, Medical Research Institute, Alexandria University, Alexandria, Egypt.

Sanaz Asemani (S)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Parsa Jamilian (P)

School of Medicine, Keele University, Staffordshire, UK.

Meysam Zarezadeh (M)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Meysam.za93@gmail.com.

Zohreh Ghoreishy (Z)

Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: zohreh.ghoreishy@gmail.com.

Classifications MeSH